← Leaderboards
Ronald J Hogg
Humana Hospital-Medical City Dallas
$1,790,283
Attributed
$1,790,283
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,790,283 · 2
By mechanism
U01$1,339,205 · 1
R01$451,078 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Young Adult Human (21-34)”
- Lloyd D Johnston · University Of Michigan At Ann Arbor$27,461,635
- Craig M Wilson · University Of Alabama At Birmingham$14,292,729
- Philip B Gorelick · Rush University Medical Center$13,477,903
- Thomas J. Coates · University Of California San Francisco$11,482,325
- Judith S Brook · Mount Sinai School Of Medicine Of Nyu$9,516,410
- David D. Celentano · Johns Hopkins University$8,405,805
Research focus
Young Adult Human (21-34)Child (0-11)Clinical TrialsHuman SubjectHuman Therapy EvaluationKidney Disorder ChemotherapyProteinuriaUrinalysisDrug Adverse EffectCreatinineCyclosporinesPatient Oriented ResearchGlomerulosclerosisPediatric PharmacologyImmunoregulationAce InhibitorsLongitudinal Human StudyMycophenolate MofetilNephrotic SyndromeBiomarkerOutcomes ResearchClinical ResearchCombination ChemotherapyEnalapril
Grant awards (7)
Comparison of Cyclosporine A and Mycophenolate in FSGS$424,454
U01 · FY2005 · DK
Comparison of Cyclosporine A and Mycophenolate in FSGS$122,172
U01 · FY2004 · DK
Comparison of Cyclosporine A and Mycophenolate in FSGS$48,862
U01 · FY2004 · DK
Comparison of Cyclosporine A and Mycophenolate in FSGS$537,603
U01 · FY2003 · DK
PILOT TRIAL IN YOUNG PATIENTS WITH IGA NEPHROPATHY$268,116
R01 · FY2002 · DK
Comparison of Cyclosporine A and Mycophenolate in FSGS$206,114
U01 · FY2002 · DK
PILOT TRIAL IN YOUNG PATIENTS WITH IGA NEPHROPATHY$182,962
R01 · FY2001 · DK